Brief: Heron Therapeutics - Pursuant To Cooperation Agreement
22/02/2023 14:39
Feb 22 (Reuters) - Heron Therapeutics Inc HRTX.O :
* HERON THERAPEUTICS - PURSUANT TO COOPERATION AGREEMENT,
EFFECTIVE ON FEB 21, 2023, BOARD INCREASED SIZE OF THE BOARD
FROM SEVEN TO EIGHT DIRECTORS
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop